Literature DB >> 21041300

Novel function of cardiac protein kinase D1 as a dynamic regulator of Ca2+ sensitivity of contraction.

Mariah H Goodall1, Robert D Wardlow, Rebecca R Goldblum, Andrew Ziman, W Jonathan Lederer, William Randall, Terry B Rogers.   

Abstract

Although the function of protein kinase D1 (PKD) in cardiac cells has remained enigmatic, recent work has shown that PKD phosphorylates the nuclear regulators HDAC5/7 (histone deacetylase 5/7) and CREB, implicating this kinase in the development of dysfunction seen in heart failure. Additional studies have shown that PKD also phosphorylates multiple sarcomeric substrates to regulate myofilament function. Initial studies examined PKD through adenoviral vector expression of wild type PKD, constitutively active PKD (caPKD), or dominant negative PKD in cultured adult rat ventricular myocytes. Confocal immunofluorescent images of these cells reveal a predominant distribution of all PKD forms in a non-nuclear, Z-line localized, striated reticular pattern, suggesting the importance of PKD in Ca(2+) signaling in heart. Consistent with an established role of PKD in targeting cardiac troponin I (cTnI), caPKD expression led to a marked decrease in contractile myofilament Ca(2+) sensitivity with an unexpected electrical stimulus dependence to this response. This desensitization was accompanied by stimulus-dependent increases in cTnI phosphorylation in control and caPKD cells with a more pronounced effect in the latter. Electrical stimulation also provoked phosphorylation of regulatory site Ser(916) on PKD. The functional importance of this phospho-Ser(916) event is demonstrated in experiments with a phosphorylation-defective mutant, caPKD-S916A, which is functionally inactive and blocks stimulus-dependent increases in cTnI phosphorylation. Dominant negative PKD expression resulted in sensitization of the myofilaments to Ca(2+) and blocked stimulus-dependent increases in cTnI phosphorylation. Taken together, these data reveal that localized PKD may play a role as a dynamic regulator of Ca(2+) sensitivity of contraction in cardiac myocytes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21041300      PMCID: PMC3009896          DOI: 10.1074/jbc.M110.179648

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

Review 1.  Protein kinase D signaling.

Authors:  Enrique Rozengurt; Osvaldo Rey; Richard T Waldron
Journal:  J Biol Chem       Date:  2005-02-08       Impact factor: 5.157

2.  Evolution of new nonantibody proteins via iterative somatic hypermutation.

Authors:  Lei Wang; W Coyt Jackson; Paul A Steinbach; Roger Y Tsien
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-19       Impact factor: 11.205

Review 3.  Control of cardiac growth by histone acetylation/deacetylation.

Authors:  Johannes Backs; Eric N Olson
Journal:  Circ Res       Date:  2006-01-06       Impact factor: 17.367

4.  Dual phospholipase C/diacylglycerol requirement for protein kinase D1 activation in lymphocytes.

Authors:  C David Wood; Ulrica Marklund; Doreen A Cantrell
Journal:  J Biol Chem       Date:  2004-12-07       Impact factor: 5.157

5.  Bombesin, vasopressin, endothelin, bradykinin, and platelet-derived growth factor rapidly activate protein kinase D through a protein kinase C-dependent signal transduction pathway.

Authors:  J L Zugaza; R T Waldron; J Sinnett-Smith; E Rozengurt
Journal:  J Biol Chem       Date:  1997-09-19       Impact factor: 5.157

6.  PKCepsilon-PKD1 signaling complex at Z-discs plays a pivotal role in the cardiac hypertrophy induced by G-protein coupling receptor agonists.

Authors:  Miki Iwata; Andrés Maturana; Masahiko Hoshijima; Kenji Tatematsu; Toshihide Okajima; Jackie R Vandenheede; Johan Van Lint; Katsuyuki Tanizawa; Shun'ichi Kuroda
Journal:  Biochem Biophys Res Commun       Date:  2005-02-25       Impact factor: 3.575

7.  Characterization of serine 916 as an in vivo autophosphorylation site for protein kinase D/Protein kinase Cmu.

Authors:  S A Matthews; E Rozengurt; D Cantrell
Journal:  J Biol Chem       Date:  1999-09-10       Impact factor: 5.157

8.  Gbetagamma-mediated regulation of Golgi organization is through the direct activation of protein kinase D.

Authors:  C Jamora; N Yamanouye; J Van Lint; J Laudenslager; J R Vandenheede; D J Faulkner; V Malhotra
Journal:  Cell       Date:  1999-07-09       Impact factor: 41.582

9.  Identification of in vivo phosphorylation sites required for protein kinase D activation.

Authors:  T Iglesias; R T Waldron; E Rozengurt
Journal:  J Biol Chem       Date:  1998-10-16       Impact factor: 5.157

10.  Protein kinase D is a novel mediator of cardiac troponin I phosphorylation and regulates myofilament function.

Authors:  Robert S Haworth; Friederike Cuello; Todd J Herron; Gereon Franzen; Jonathan C Kentish; Mathias Gautel; Metin Avkiran
Journal:  Circ Res       Date:  2004-10-28       Impact factor: 17.367

View more
  9 in total

1.  Myosin binding protein-C slow is a novel substrate for protein kinase A (PKA) and C (PKC) in skeletal muscle.

Authors:  Maegen A Ackermann; Aikaterini Kontrogianni-Konstantopoulos
Journal:  J Proteome Res       Date:  2011-09-22       Impact factor: 4.466

Review 2.  G protein-dependent and G protein-independent signaling pathways and their impact on cardiac function.

Authors:  Douglas G Tilley
Journal:  Circ Res       Date:  2011-07-08       Impact factor: 17.367

3.  Protein kinase D controls voluntary-running-induced skeletal muscle remodelling.

Authors:  Kornelia Ellwanger; Christine Kienzle; Sylke Lutz; Zheng-Gen Jin; Maria T Wiekowski; Klaus Pfizenmaier; Angelika Hausser
Journal:  Biochem J       Date:  2011-12-15       Impact factor: 3.857

4.  Protein kinase D3 is a pivotal activator of pathological cardiac hypertrophy by selectively increasing the expression of hypertrophic transcription factors.

Authors:  Changlin Li; Jing Li; Xiangyu Cai; Haili Sun; Jinjin Jiao; Ting Bai; Xing Wang Zhou; Xiongwen Chen; Donald L Gill; Xiang D Tang
Journal:  J Biol Chem       Date:  2011-10-04       Impact factor: 5.157

Review 5.  Integration of troponin I phosphorylation with cardiac regulatory networks.

Authors:  R John Solaro; Marcus Henze; Tomoyoshi Kobayashi
Journal:  Circ Res       Date:  2013-01-18       Impact factor: 17.367

6.  The C-terminus of the long AKAP13 isoform (AKAP-Lbc) is critical for development of compensatory cardiac hypertrophy.

Authors:  Domenico M Taglieri; Keven R Johnson; Brian T Burmeister; Michelle M Monasky; Matthew J Spindler; Jaime DeSantiago; Kathrin Banach; Bruce R Conklin; Graeme K Carnegie
Journal:  J Mol Cell Cardiol       Date:  2013-10-23       Impact factor: 5.000

7.  PKCβII modulation of myocyte contractile performance.

Authors:  Hyosook Hwang; Dustin A Robinson; Tamara K Stevenson; Helen C Wu; Sarah E Kampert; Francis D Pagani; D Brad Dyke; Jody L Martin; Sakthival Sadayappan; Sharlene M Day; Margaret V Westfall
Journal:  J Mol Cell Cardiol       Date:  2012-05-14       Impact factor: 5.000

8.  β-adrenergic signaling inhibits Gq-dependent protein kinase D activation by preventing protein kinase D translocation.

Authors:  C Blake Nichols; Chia-Wei Chang; Maura Ferrero; Brent M Wood; Matthew L Stein; Amanda J Ferguson; Derrick Ha; Robert R Rigor; Sven Bossuyt; Julie Bossuyt
Journal:  Circ Res       Date:  2014-03-18       Impact factor: 17.367

Review 9.  cMyBP-C as a promiscuous substrate: phosphorylation by non-PKA kinases and its potential significance.

Authors:  Sonya C Bardswell; Friederike Cuello; Jonathan C Kentish; Metin Avkiran
Journal:  J Muscle Res Cell Motil       Date:  2011-11-17       Impact factor: 2.698

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.